<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="systematic-review" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id>
<journal-title>Frontiers in Pediatrics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pediatr.</abbrev-journal-title>
<issn pub-type="epub">2296-2360</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fped.2025.1512689</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pediatrics</subject>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Risk factors for refractory <italic>Mycoplasma pneumoniae</italic> in Chinese children: a meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Chun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2112875/overview"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Shan</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Chuanzhong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/680474/overview" /><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xiaolan</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Luohui</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Yuejuan</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/3107892/overview"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Cao</surname><given-names>Min</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/3107878/overview"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Department of Neonatology, Shenzhen Maternity &#x0026; Child Healthcare Hospital</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Department of Emergency, Shenzhen Maternity &#x0026; Child Healthcare Hospital</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Milos Jesenak, Comenius University, Slovakia</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Peter Durdik, Comenius University, Slovakia</p>
<p>Peng Liu, University of South China, China</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Yuejuan Wang <email>yuejuanwanggz@126.com</email> Min Cao <email>13502846551@139.com</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>27</day><month>06</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>13</volume><elocation-id>1512689</elocation-id>
<history>
<date date-type="received"><day>17</day><month>10</month><year>2024</year></date>
<date date-type="accepted"><day>16</day><month>06</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025 Chen, Chen, Yang, Zhang, Liu, Wang and Cao.</copyright-statement>
<copyright-year>2025</copyright-year><copyright-holder>Chen, Chen, Yang, Zhang, Liu, Wang and Cao</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>With the increase of the incidence rate of <italic>Mycoplasma pneumoniae</italic> in children and the widespread use of azithromycin, the number of cases of refractory <italic>M. pneumoniae</italic> increased accordingly. <italic>M. pneumoniae</italic> infection was generally considered a self-limiting disease. However, under certain special circumstances, it was highly likely to develop into a refractory disease. This study conducted a meta-analysis of early risk factors for refractory <italic>Mycoplasma pneumoniae</italic> pneumonia (RMPP), which was helpful for the early clinical diagnosis of RMPP and the reduction of sequelae.</p>
</sec><sec><title>Methods</title>
<p>This systematic search was conducted in Web of Science, Embase, PubMed, Cochrane Library, CNKI, Wangfang, Sinomed and Cqvip, and the date was set until August 20, 2024. After two researchers independently screened the literature, extracted data, and assessed the risk of bias in the included studies, a meta-analysis was conducted using STATA 17.0 and RevMan 5.4 software.</p>
</sec><sec><title>Results</title>
<p>Twenty-eight studies including 6374 patients were included in this analysis, and the results showed that the age [<italic>MD (95&#x0025; CI)</italic>: 0.62 (0.21, 1.03), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.003], LDH [<italic>MD (95&#x0025; CI</italic>): 161.57 (128.22, 194.91), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001], neutrophils (&#x0025;) [<italic>MD (95&#x0025; CI</italic>): 9.27 (3.45, 15.09), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.002], IL-6 [<italic>MD (95&#x0025; CI</italic>): 23.07 (20.90, 25.24), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.04], ESR [<italic>MD (95&#x0025; CI</italic>): 10.93 (7.75, 14.11), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001], AST [<italic>MD (95&#x0025; CI</italic>): 16.11 (8.21, 24.01), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001], ALT [<italic>MD (95&#x0025; CI</italic>): 23.69 (9.60, 37.77), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.001], CRP [<italic>MD (95&#x0025; CI</italic>): 23.72 (18.41, 29.03), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001], and WBC [<italic>MD (95&#x0025; CI</italic>): 1.07 (0.28, 1.86), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.008] were higher in the RMPP group than in the NRMPP group. Combined pleural effusion (<italic>OR</italic>&#x2009;&#x003D;&#x2009;7.59, <italic>95&#x0025; CI</italic>: 4.19&#x2013;13.75, <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001) and lung consolidation (<italic>OR</italic>&#x2009;&#x003D;&#x2009;10.61, <italic>95&#x0025; CI</italic>: 4.13&#x2013;27.26, <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001) were identified as risk factors for RMPP. However, no significant association was found between gender and the incidence of RMPP (<italic>OR</italic>&#x2009;&#x003D;&#x2009;0.91, <italic>95&#x0025; CI</italic>: 0.80&#x2013;1.02, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.10). The analysis of publication bias indicated that 3 of the 11 factors analyzed [LDH, neutrophils (&#x0025;), and lung consolidation] showed significant publication bias (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.05).</p>
</sec><sec><title>Conclusion</title>
<p>Our study further confirmed that elevated inflammatory markers such as CRP, LDH, neutrophils (&#x0025;), IL-6, ESR, lung consolidation, combined pleural effusion were risk factors for RMPP. For the first time, WBC, ALT, and AST were identified as risk factors for the occurrence of RMPP in children. Additionally, demographic information such as age and gender was also examined in relation to RMPP in children.</p>
</sec>
</abstract>
<kwd-group>
<kwd>refractory <italic>mycoplasma pneumoniae</italic></kwd>
<kwd>child</kwd>
<kwd>children</kwd>
<kwd>riskfactors</kwd>
<kwd>meta-analysis</kwd>
</kwd-group><counts>
<fig-count count="15"/>
<table-count count="2"/><equation-count count="0"/><ref-count count="48"/><page-count count="13"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Pediatric Pulmonology</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p><italic>Mycoplasma pneumoniae</italic>, an obligate intracellular pathogen without a cell wall, had various virulence factors enabling it to overcome host defenses. Its infection triggered immune responses like leukocyte pro-inflammatory effects and epithelial cell metabolic changes, causing severe respiratory symptoms in humans, particularly children (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). <italic>M. pneumoniae</italic> infections could also lead to extrapulmonary manifestations in multiple systems (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). RMPP occurred when patients still had fever, persistent symptoms, worsening lung imaging and even extrapulmonary complications after 7 days of macrolide antibiotic treatment. Severe cases might endanger pediatric patients&#x0027; lives and lead to complications like obliterative bronchitis, bronchiectasis and interstitial lung disease, which could reduce exercise tolerance and quality of life (<xref ref-type="bibr" rid="B5">5</xref>). Due to its high antibiotic resistance rate, while vaccination was being studied (<xref ref-type="bibr" rid="B6">6</xref>), early RMPP recognition via clinical indices was crucial for pediatric clinicians to shorten the disease course, alleviate family economic burdens and reduce children&#x0027;s suffering. The high RMPP incidence in Asia had made it a clinical research hotspot (<xref ref-type="bibr" rid="B7">7</xref>). Studies had indicated that LDH, CRP, neutrophils (&#x0025;), D-dimer, and ESR were RMPP risk factors (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>), but some research had found contradictory results (<xref ref-type="bibr" rid="B11">11</xref>). The elusive pathogenesis of pediatric RMPP underscored the need to study risk factors for early high-risk identification and management, given its rising incidence, multifarious complications, and suboptimal outcomes. This meta-analysis investigated RMPP risk factors to provide evidence-based clinical guidance for early intervention.</p>
</sec>
<sec id="s2" sec-type="methods"><label>2</label><title>Methods</title>
<sec id="s2a"><label>2.1</label><title>Databases</title>
<p>English databases included PubMed, Embase, Cochrane Library, and Web of Science. Chinese databases include China National Knowledge Infrastructure (CNKI), Wanfang, Cqvip, and SinoMed. The search time was set from the establishment of each database to August 20, 2024. We selected literature that had publicly publishes research on the risk factors of pediatric refractory <italic>M. pneumoniae</italic> pneumonia.</p>
</sec>
<sec id="s2b"><label>2.2</label><title>Search strategies</title>
<p>The retrieval strategy adopted a combination of subject headings and free text keywords, adjusted according to the characteristics of each database. The search method was &#x201C;<italic>M. pneumoniae</italic> pneumonia&#x201D; OR &#x201C;MPP&#x201D; OR &#x201C;refractory <italic>M. pneumoniae</italic> pneumonia&#x201D; OR &#x201C;RMPP&#x201D; AND &#x201C;children&#x201D; OR &#x201C;child&#x201D; AND &#x201C;factor&#x201D; OR &#x201C;risk&#x201D;. Taking the PubMed search strategy as an example, it was presented in <xref ref-type="sec" rid="s11">Supplementary Table S1</xref>.</p>
</sec>
<sec id="s2c"><label>2.3</label><title>Inclusion and exclusion</title>
<p>Inclusion criteria:
<list list-type="simple">
<list-item><label>(1)</label>
<p>The types of study included cohort studies or case-control studies.</p></list-item>
<list-item><label>(2)</label>
<p>The case group consisted of children with RMPP, while the control group consisted of children with typical <italic>M. pneumoniae</italic> pneumonia.</p></list-item>
<list-item><label>(3)</label>
<p>Articles in Chinese (from core journals) and articles in English.</p></list-item>
</list>Exclusion criteria:
<list list-type="simple">
<list-item><label>(1)</label>
<p>studies with duplicate publications;</p></list-item>
<list-item><label>(2)</label>
<p>conference abstracts, reviews, case reports, meta-analyses or editorials;</p></list-item>
<list-item><label>(3)</label>
<p>studies with incomplete data records;</p></list-item>
<list-item><label>(4)</label>
<p>animal experimental research.</p></list-item>
</list></p>
</sec>
<sec id="s2d"><label>2.4</label><title>Data extraction</title>
<p>Two researchers separately conducted literature screening, data extraction, and peer&#x2014;checking. If conflicting data emerged, a third researcher made a judgment. The literature screening process was as follows: &#x2460; Screen titles to exclude obviously irrelevant literature; &#x2461; Read abstracts and full texts to determine inclusion. They used EXCEL to extract key information, including the first author, publication year, study region, research year, literature type, total number and age of case/control groups, and outcome indicators.</p>
</sec>
<sec id="s2e"><label>2.5</label><title>Quality assessment</title>
<p>The Newcastle-Ottawa Scale (NOS) was employed to evaluate the quality of the eligible observational studies. The NOS is a composite assessment strategy that provides one score for each study based on questions related to 3 key domains: selection bias, comparability for assessment of confounding, and outcome/exposure definition. Standard questionnaires are available for cohort and case&#x2013;control studies. The total score of NOS was 9 points, and the research quality was divided into low quality (0&#x2013;3 scores), medium quality (4&#x2013;6 scores), and high quality (7&#x2013;9 scores). The details of methodological quality assessment of included studies were showed in <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>.</p>
</sec>
<sec id="s2f"><label>2.6</label><title>Statistical analysis</title>
<p>Forest plots were used to display effect sizes and confidence intervals for each outcome in the meta-analysis, as well as the overall summary effect. Heterogeneity testing assessed various indicators. When the heterogeneity statistic I<sup>2</sup> was less than 50&#x0025;, the fixed effects model was adopted; Otherwise, random effects model was used. Binary variables used odds ratio (OR) as the effect analysis statistic, continuous variables used mean difference (MD) as the effect analysis statistic, and provide a 95&#x0025; confidence interval (CI) was provided for each effect size. Sensitivity analysis was conducted on the model, and publication bias was detected through Egger&#x0027;s test. The difference was considered statistically significant when <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05. When the number of included studies based on outcome indicators was &#x2265;10, funnel plots were used to analyze publication bias. Meta-analysis was conducted using STATA 17.0 software and Review Manager version 5.3.0.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><label>3</label><title>Results</title>
<sec id="s3a"><label>3.1</label><title>Literature screening process</title>
<p>A total of 5,258 articles were retrieved. After removing duplicate literature, 3,006 articles remained, and 28 studies were selected based on inclusion and exclusion criteria. <xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref> illustrates the detailed literature search process.</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Retrieval flow chart.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g001.tif"><alt-text content-type="machine-generated">Flowchart illustrating the selection process for a meta-analysis. It begins with 4,328 records from database searches and 930 from other sources. After removing duplicates, 3,006 records remain. From these, 460 records are selected for review based on titles and abstracts. A total of 2,546 records are excluded for reasons such as being reviews, meta-analyses, abstracts, case reports, animal experiments, or not meeting requirements. Further assessment of 88 full-text reports results in the exclusion of 60, leaving 28 studies included in the meta-analysis.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3b"><label>3.2</label><title>Basic feature</title>
<p>The included literature types were case-control studies published between 2012 and 2024, with a total sample size of 6,374 cases. There were a total of 23 high-quality studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>) and 5 medium-quality studies (<xref ref-type="bibr" rid="B33">33</xref>&#x2013;<xref ref-type="bibr" rid="B37">37</xref>). The results of the literature quality evaluation were shown in <xref ref-type="table" rid="T1">Table&#x00A0;1</xref>, and the characteristics of the studies were shown in <xref ref-type="table" rid="T2">Table&#x00A0;2</xref>.</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Baseline characteristics.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">Author</th>
<th valign="top" align="center" rowspan="2">Publication year</th>
<th valign="top" align="center" rowspan="2">Study year</th>
<th valign="top" align="center" colspan="2">Total</th>
<th valign="top" align="center" colspan="2">Age, years</th>
<th valign="top" align="center" rowspan="2">Quality assessment</th>
<th valign="top" align="center" rowspan="2">Grade of evidence</th>
</tr>
<tr>
<th valign="top" align="center">E</th>
<th valign="top" align="center">C</th>
<th valign="top" align="center">E</th>
<th valign="top" align="center">C</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Xu et al. (<xref ref-type="bibr" rid="B25">25</xref>)</td>
<td valign="top" align="center">2024</td>
<td valign="top" align="center">2019&#x2013;2020</td>
<td valign="top" align="center">55</td>
<td valign="top" align="center">391</td>
<td valign="top" align="center">5.0</td>
<td valign="top" align="center">5.2</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Chen et al. (<xref ref-type="bibr" rid="B28">28</xref>)</td>
<td valign="top" align="center">2024</td>
<td valign="top" align="center">2021&#x2013;2022</td>
<td valign="top" align="center">156</td>
<td valign="top" align="center">312</td>
<td valign="top" align="center">6.2&#x2009;&#x00B1;&#x2009;2.9,</td>
<td valign="top" align="center">5.6&#x2009;&#x00B1;&#x2009;3.0</td>
<td valign="top" align="center">9</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Li et al. (<xref ref-type="bibr" rid="B32">32</xref>)</td>
<td valign="top" align="center">2024</td>
<td valign="top" align="center">2018&#x2013;2022</td>
<td valign="top" align="center">56</td>
<td valign="top" align="center">70</td>
<td valign="top" align="center">5.1&#x2009;&#x00B1;&#x2009;3.4,</td>
<td valign="top" align="center">4.9&#x2009;&#x00B1;&#x2009;3.1</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Li et al. (<xref ref-type="bibr" rid="B31">31</xref>)</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="center">2020&#x2013;2021</td>
<td valign="top" align="center">120</td>
<td valign="top" align="center">109</td>
<td valign="top" align="center">7.3&#x2009;&#x00B1;&#x2009;2.1,</td>
<td valign="top" align="center">7.4&#x2009;&#x00B1;&#x2009;2.3</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Wei et al. (<xref ref-type="bibr" rid="B24">24</xref>)</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="center">2019&#x2013;2021</td>
<td valign="top" align="center">70</td>
<td valign="top" align="center">70</td>
<td valign="top" align="center">4.9&#x2009;&#x00B1;&#x2009;1.7,</td>
<td valign="top" align="center">5.5&#x2009;&#x00B1;&#x2009;2.0</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Gao et al. (<xref ref-type="bibr" rid="B24">24</xref>)</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="center">2019&#x2013;2021</td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">42</td>
<td valign="top" align="center">5.5</td>
<td valign="top" align="center">4.2</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Zhang et al. (<xref ref-type="bibr" rid="B30">30</xref>)</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="center">2017&#x2013;2018</td>
<td valign="top" align="center">35</td>
<td valign="top" align="center">30</td>
<td valign="top" align="center">4.8&#x2009;&#x00B1;&#x2009;2.6</td>
<td valign="top" align="center">4.6&#x2009;&#x00B1;&#x2009;2.9</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Li et al. (<xref ref-type="bibr" rid="B17">17</xref>)</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="center">2018&#x2013;2021</td>
<td valign="top" align="center">131</td>
<td valign="top" align="center">386</td>
<td valign="top" align="center">6.0</td>
<td valign="top" align="center">4.8</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Fu et al. (<xref ref-type="bibr" rid="B21">21</xref>)</td>
<td valign="top" align="center">2022</td>
<td valign="top" align="center">2019&#x2013;2021</td>
<td valign="top" align="center">82</td>
<td valign="top" align="center">156</td>
<td valign="top" align="center">5.9&#x2009;&#x00B1;&#x2009;2.4</td>
<td valign="top" align="center">5.5&#x2009;&#x00B1;&#x2009;2.3</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Su et al. (<xref ref-type="bibr" rid="B37">37</xref>)</td>
<td valign="top" align="center">2022</td>
<td valign="top" align="center">2021</td>
<td valign="top" align="center">41</td>
<td valign="top" align="center">101</td>
<td valign="top" align="center">2.6</td>
<td valign="top" align="center">2.0</td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">Medium</td>
</tr>
<tr>
<td valign="top" align="left">Shen et al. (<xref ref-type="bibr" rid="B29">29</xref>)</td>
<td valign="top" align="center">2022</td>
<td valign="top" align="center">2018&#x2013;2021</td>
<td valign="top" align="center">156</td>
<td valign="top" align="center">143</td>
<td valign="top" align="center">6.8&#x2009;&#x00B1;&#x2009;2.3</td>
<td valign="top" align="center">7.2&#x2009;&#x00B1;&#x2009;2.2</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Huang et al. (<xref ref-type="bibr" rid="B9">9</xref>)</td>
<td valign="top" align="center">2022</td>
<td valign="top" align="center">2019&#x2013;2021</td>
<td valign="top" align="center">31</td>
<td valign="top" align="center">17</td>
<td valign="top" align="center">4.8&#x2009;&#x00B1;&#x2009;3.5</td>
<td valign="top" align="center">4.8&#x2009;&#x00B1;&#x2009;3.2</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Li et al. (<xref ref-type="bibr" rid="B15">15</xref>)</td>
<td valign="top" align="center">2021</td>
<td valign="top" align="center">2016&#x2013;2020</td>
<td valign="top" align="center">125</td>
<td valign="top" align="center">125</td>
<td valign="top" align="center">&#x2014;</td>
<td valign="top" align="center">&#x2014;</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Wen et al. (<xref ref-type="bibr" rid="B19">19</xref>)</td>
<td valign="top" align="center">2021</td>
<td valign="top" align="center">2019&#x2013;2020</td>
<td valign="top" align="center">88</td>
<td valign="top" align="center">216</td>
<td valign="top" align="center">6.5&#x2009;&#x00B1;&#x2009;2.5</td>
<td valign="top" align="center">6.1&#x2009;&#x00B1;&#x2009;2.4</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Huang et al. (<xref ref-type="bibr" rid="B20">20</xref>)</td>
<td valign="top" align="center">2021</td>
<td valign="top" align="center">2019</td>
<td valign="top" align="center">22</td>
<td valign="top" align="center">50</td>
<td valign="top" align="center">1.7</td>
<td valign="top" align="center">2.2</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Huang et al. (<xref ref-type="bibr" rid="B9">9</xref>)</td>
<td valign="top" align="center">2021</td>
<td valign="top" align="center">2015</td>
<td valign="top" align="center">124</td>
<td valign="top" align="center">306</td>
<td valign="top" align="center">5.7&#x2009;&#x00B1;&#x2009;2.7</td>
<td valign="top" align="center">4.3&#x2009;&#x00B1;&#x2009;2.5</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Zheng et al. (<xref ref-type="bibr" rid="B12">12</xref>)</td>
<td valign="top" align="center">2020</td>
<td valign="top" align="center">2013&#x2013;2019</td>
<td valign="top" align="center">73</td>
<td valign="top" align="center">146</td>
<td valign="top" align="center">6.5&#x2009;&#x00B1;&#x2009;2.5</td>
<td valign="top" align="center">6.4&#x2009;&#x00B1;&#x2009;2.8</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Guo et al. (<xref ref-type="bibr" rid="B14">14</xref>)</td>
<td valign="top" align="center">2020</td>
<td valign="top" align="center">2014&#x2013;2018</td>
<td valign="top" align="center">94</td>
<td valign="top" align="center">60</td>
<td valign="top" align="center">6.4&#x2009;&#x00B1;&#x2009;1.3</td>
<td valign="top" align="center">6.3&#x2009;&#x00B1;&#x2009;2.1</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Sun et al. (<xref ref-type="bibr" rid="B22">22</xref>)</td>
<td valign="top" align="center">2020</td>
<td valign="top" align="center">2016&#x2013;2018</td>
<td valign="top" align="center">36</td>
<td valign="top" align="center">53</td>
<td valign="top" align="center">6.9&#x2009;&#x00B1;&#x2009;2.0</td>
<td valign="top" align="center">7.2&#x2009;&#x00B1;&#x2009;1.8</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Li et al. (<xref ref-type="bibr" rid="B33">33</xref>)</td>
<td valign="top" align="center">2019</td>
<td valign="top" align="center">2018</td>
<td valign="top" align="center">58</td>
<td valign="top" align="center">166</td>
<td valign="top" align="center">6.3&#x2009;&#x00B1;&#x2009;2.7</td>
<td valign="top" align="center">3.4&#x2009;&#x00B1;&#x2009;1.3</td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">Medium</td>
</tr>
<tr>
<td valign="top" align="left">Guo et al. (<xref ref-type="bibr" rid="B35">35</xref>)</td>
<td valign="top" align="center">2019</td>
<td valign="top" align="center">2017&#x2013;2018</td>
<td valign="top" align="center">220</td>
<td valign="top" align="center">80</td>
<td valign="top" align="center">6.1&#x2009;&#x00B1;&#x2009;1.6</td>
<td valign="top" align="center">5.6&#x2009;&#x00B1;&#x2009;1.4</td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">Medium</td>
</tr>
<tr>
<td valign="top" align="left">Zhai et al. (<xref ref-type="bibr" rid="B13">13</xref>)</td>
<td valign="top" align="center">2017</td>
<td valign="top" align="center">2012&#x2013;2016</td>
<td valign="top" align="center">142</td>
<td valign="top" align="center">486</td>
<td valign="top" align="center">6.8&#x2009;&#x00B1;&#x2009;2.5</td>
<td valign="top" align="center">4.6&#x2009;&#x00B1;&#x2009;1.9</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Li et al. (<xref ref-type="bibr" rid="B16">16</xref>)</td>
<td valign="top" align="center">2017</td>
<td valign="top" align="center">2013&#x2013;2016</td>
<td valign="top" align="center">92</td>
<td valign="top" align="center">161</td>
<td valign="top" align="center">6.5&#x2009;&#x00B1;&#x2009;2.8</td>
<td valign="top" align="center">5.5&#x2009;&#x00B1;&#x2009;2.5</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Yao et al. (<xref ref-type="bibr" rid="B26">26</xref>)</td>
<td valign="top" align="center">2016</td>
<td valign="top" align="center">2013&#x2013;2014</td>
<td valign="top" align="center">29</td>
<td valign="top" align="center">68</td>
<td valign="top" align="center">5.3&#x2009;&#x00B1;&#x2009;3.0</td>
<td valign="top" align="center">4.4&#x2009;&#x00B1;&#x2009;2.9</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Shao et al. (<xref ref-type="bibr" rid="B36">36</xref>)</td>
<td valign="top" align="center">2015</td>
<td valign="top" align="center">2013&#x2013;2014</td>
<td valign="top" align="center">35</td>
<td valign="top" align="center">158</td>
<td valign="top" align="center">&#x2014;</td>
<td valign="top" align="center">&#x2014;</td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">Medium</td>
</tr>
<tr>
<td valign="top" align="left">Wang et al. (<xref ref-type="bibr" rid="B23">23</xref>)</td>
<td valign="top" align="center">2015</td>
<td valign="top" align="center">2014&#x2013;2015</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">110</td>
<td valign="top" align="center">6.9&#x2009;&#x00B1;&#x2009;2.8</td>
<td valign="top" align="center">5.7&#x2009;&#x00B1;&#x2009;2.8</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Lu et al. (<xref ref-type="bibr" rid="B18">18</xref>)</td>
<td valign="top" align="center">2014</td>
<td valign="top" align="center">2012&#x2013;2013</td>
<td valign="top" align="center">353</td>
<td valign="top" align="center">300</td>
<td valign="top" align="center">6.9&#x2009;&#x00B1;&#x2009;2.8</td>
<td valign="top" align="center">5.7&#x2009;&#x00B1;&#x2009;2.8</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">High</td>
</tr>
<tr>
<td valign="top" align="left">Liu et al. (<xref ref-type="bibr" rid="B34">34</xref>)</td>
<td valign="top" align="center">2012</td>
<td valign="top" align="center">2006&#x2013;2012</td>
<td valign="top" align="center">72</td>
<td valign="top" align="center">141</td>
<td valign="top" align="center">&#x2014;</td>
<td valign="top" align="center">&#x2014;</td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">Medium</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Publication bias.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Factors</th>
<th valign="top" align="center"><italic>t</italic> value</th>
<th valign="top" align="center"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">LDH</td>
<td valign="top" align="center">&#x2212;6.85</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">WBC</td>
<td valign="top" align="center">0.54</td>
<td valign="top" align="center">0.592</td>
</tr>
<tr>
<td valign="top" align="left">IL-6</td>
<td valign="top" align="center">&#x2212;1.88</td>
<td valign="top" align="center">0.061</td>
</tr>
<tr>
<td valign="top" align="left">AST</td>
<td valign="top" align="center">&#x2212;0.84</td>
<td valign="top" align="center">0.400</td>
</tr>
<tr>
<td valign="top" align="left">ALT</td>
<td valign="top" align="center">1.92</td>
<td valign="top" align="center">0.055</td>
</tr>
<tr>
<td valign="top" align="left">Neutrophils (&#x0025;)</td>
<td valign="top" align="center">&#x2212;2.27</td>
<td valign="top" align="center">0.023</td>
</tr>
<tr>
<td valign="top" align="left">CRP</td>
<td valign="top" align="center">&#x2212;0.90</td>
<td valign="top" align="center">0.371</td>
</tr>
<tr>
<td valign="top" align="left">ESR</td>
<td valign="top" align="center">0.07</td>
<td valign="top" align="center">0.948</td>
</tr>
<tr>
<td valign="top" align="left">Fever duration</td>
<td valign="top" align="center">0.11</td>
<td valign="top" align="center">0.915</td>
</tr>
<tr>
<td valign="top" align="left">Lung Consolidation</td>
<td valign="top" align="center">&#x2212;2.81</td>
<td valign="top" align="center">0.005</td>
</tr>
<tr>
<td valign="top" align="left">Combined pleural effusion</td>
<td valign="top" align="center">&#x2212;1.07</td>
<td valign="top" align="center">0.285</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3c"><label>3.3</label><title>Meta-analysis results</title>
<sec id="s3c1"><label>3.3.1</label><title>The age</title>
<p>The forest plot presented a meta-analysis examining the impact of age on the incidence of RMPP. The analysis included 20 studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B21">21</xref>&#x2013;<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B28">28</xref>&#x2013;<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>) with a total of 2,047 participants in the RMPP group and 3,059 in the NRMPP roup. The overall mean difference in age between the groups was 0.62 (<italic>95&#x0025; CI</italic>: 0.21, 1.03), favoring the RMPP group. Significant heterogeneity was observed (<italic>Tau</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;0.72; <italic>Chi</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;151.91, <italic>df</italic>&#x2009;&#x003D;&#x2009;19, <italic>P</italic>&#x2009;<italic>&#x003C;</italic>&#x2009;0.00001; <italic>I</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;87&#x0025;), indicating variability in results across studies. The overall effect was significant (<italic>Z</italic>&#x2009;&#x003D;&#x2009;2.94, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.003), suggesting that age was a relevant factor in RMPP incidence (<xref ref-type="fig" rid="F2">Figure&#x00A0;2A</xref>). This funnel plot assessed publication bias for the relationship between age and RMPP in children. The symmetrical distribution of points around the vertical line suggested low risk of publication bias, indicating that the study results were likely reliable (<xref ref-type="fig" rid="F2">Figure&#x00A0;2B</xref>).</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p><bold>(A)</bold> Estimated MD summary for age. <bold>(B)</bold> Funnel plot for publication bias risk of age.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g002.tif"><alt-text content-type="machine-generated">Forest plot and funnel plot of a meta-analysis. The forest plot shows studies comparing experimental and control groups with mean differences and confidence intervals. The pooled effect size is 0.62 with significant heterogeneity. The funnel plot displays study scatter showing publication bias, shaped around a central line, with dotted lines forming a triangle.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c2"><label>3.3.2</label><title>Gender</title>
<p>The analysis included a total of 23 studies (<xref ref-type="bibr" rid="B7">7</xref>&#x2013;<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B34">34</xref>&#x2013;<xref ref-type="bibr" rid="B37">37</xref>), with 1,964 participants in the RMPP group and 3,262 in the NRMPP group. The overall odds ratio (<italic>OR</italic>) was 0.91 (<italic>95&#x0025; CI</italic>: 0.80, 1.02), indicating no significant association between gender and the incidence of RMPP. The heterogeneity test (<italic>Chi</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;26.98, <italic>df</italic>&#x2009;&#x003D;&#x2009;22, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.21) indicated no significant heterogeneity among studies, and the overall effect test (<italic>Z</italic>&#x2009;&#x003D;&#x2009;1.65, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.10) showed no significant overall effect (<xref ref-type="fig" rid="F3">Figure&#x00A0;3A</xref>). The funnel plot in this meta-analysis displayed the distribution of studies based on their effect size (odds ratio) and sample size (indicated by the weight). The plot showed a relatively symmetrical distribution of studies around the overall effect size, suggesting low risk of publication bias (<xref ref-type="fig" rid="F3">Figure&#x00A0;3B</xref>).</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p><bold>(A)</bold> Estimated OR summary for gender. <bold>(B)</bold> Funnel plot for publication bias risk of gender.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g003.tif"><alt-text content-type="machine-generated">Forest plot and funnel plot from a meta-analysis. The forest plot on the left shows odds ratios with 95&#x0025; confidence intervals for studies comparing experimental and control groups across multiple studies. The summary effect size is indicated by a diamond. The funnel plot on the right displays the standard error of the log odds ratios with studies distributed around the line of no effect, indicating symmetrical distribution.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c3"><label>3.3.3</label><title>CRP</title>
<p>A total of 13 studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B34">34</xref>&#x2013;<xref ref-type="bibr" rid="B37">37</xref>) reported the association between CRP levels and RMPP, including 3,651 cases. The heterogeneity results showed an <italic>I</italic><sup>2</sup> of 99&#x0025;, <italic>P</italic>&#x2009;&#x003C;&#x2009;0.00001, indicating high heterogeneity among the studies. The random effects model was used for meta-analysis. The results indicated that the CRP levels in the RMPP group were higher than those in the NRMPP group, and the difference was statistically significant [<italic>MD</italic> (<italic>95&#x0025; CI</italic>): 23.72 (18.41, 29.03), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001]. The funnel plot indicated a potential risk of publication bias. The points were mostly clustered around the center, but there were a few points that deviated significantly from the central line. This suggested that smaller studies with more significant effects might have been more likely to be published, while smaller studies with non&#x2014;significant or negative results might have been less likely to be published. These findings are shown in <xref ref-type="fig" rid="F4">Figures&#x00A0;4A,B</xref>. The subgroup analysis of the CRP outcome by age range (&#x003C;12 years vs. &#x2265;12 years) showed that in the &#x2265;12 years subgroup, CRP in the RMPP group was significantly higher than that in the NRMPP group (with a stable effect), while in the &#x003C;12 years subgroup, the results should be interpreted with caution due to high heterogeneity. Both the overall and subgroup heterogeneities were extremely strong, and age had a significant modifying effect on the CRP effect under the Common effect model (<xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>).</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p><bold>(A)</bold> Estimated MD summary for CRP. <bold>(B)</bold> Funnel plot for publication bias risk of CRP.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g004.tif"><alt-text content-type="machine-generated">Forest plot with studies comparing experimental and control groups. Each study shows mean, standard deviation, and sample size. Mean differences with confidence intervals are plotted, indicating favorability towards the experimental group. Heterogeneity is significant. A funnel plot illustrates distribution of study results, suggesting some asymmetry, with most data points clustering around zero mean difference.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c4"><label>3.3.4</label><title>LDH</title>
<p>A total of 10 articles (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B36">36</xref>) were combined to analyze LDH, including 3,021 patients, the heterogeneity test after merging showed statistical significance (<italic>I</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;95&#x0025;). The results of the random effects model showed that the LDH levels in the RMPP group were higher than those in the NRMPP group, and the difference was statistically significant [<italic>MD</italic> (<italic>95&#x0025; CI</italic>): 161.57 (128.22, 194.91), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001], as shown in <xref ref-type="fig" rid="F5">Figure&#x00A0;5A</xref>. The funnel plot showed asymmetry, indicating a potential risk of publication bias. The points were unevenly distributed around the central line, with more studies having positive results. This suggested possible underrepresentation of studies with negative or non-significant findings (<xref ref-type="fig" rid="F5">Figure&#x00A0;5B</xref>). The subgroup analysis of the LDH outcome stratified by age range revealed that, in both subgroups, the LDH levels in the RMPP group were significantly elevated compared to those in the NRMPP group (with extremely high heterogeneity), and age exerted a significant modifying effect on the LDH response under the Common effect model (with more marked differences observed in the &#x2265;12 years subgroup). (<xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>).</p>
<fig id="F5" position="float"><label>Figure 5</label>
<caption><p><bold>(A)</bold> Estimated MD summary for LDH. <bold>(B)</bold> Funnel plot for publication bias risk of LDH.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g005.tif"><alt-text content-type="machine-generated">Forest plot showing mean differences between experimental and control groups across several studies, with confidence intervals. A total mean difference of 161.57 is indicated. Heterogeneity statistics are provided, with I2 at 95&#x0025;. A funnel plot to the right assesses publication bias.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c5"><label>3.3.5</label><title>Combination of CRP and LDH levels</title>
<p>The forest plot (<xref ref-type="fig" rid="F6">Figure&#x00A0;6</xref>) showed a meta-analysis using combined CRP and LDH levels to predict RMPP in children. It included eight studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B36">36</xref>), and found a significant mean difference of 89.37 (<italic>95&#x0025;CI</italic>: 65.40, 113.35) favoring the RMPP group, with high heterogeneity (<italic>I</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;96&#x0025;). This indicated that while the combined markers were effective, the results varied widely across studies, suggesting a need for further research to refine the risk model.</p>
<fig id="F6" position="float"><label>Figure 6</label>
<caption><p>Estimated MD summary for combination of CRP and LDH levels.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g006.tif"><alt-text content-type="machine-generated">Forest plot showing mean differences with 95&#x0025; confidence intervals for eight studies comparing experimental and control groups. The overall effect estimates a mean difference of 89.37, favoring the experimental group, with substantial heterogeneity indicated (I squared equals 96 percent).</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c6"><label>3.3.6</label><title>WBC</title>
<p>A total of 13 studies on WBC (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B36">36</xref>) were merged and analyzed, including 3084 patients. The heterogeneity test after merging showed statistical differences (<italic>I</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;92&#x0025;). Therefore, a random effects model was used. The results showed that the WBC levels in the RMPP group were slightly higher than those in the NRMPP group, and the difference was statistically significant [<italic>MD</italic> (<italic>95&#x0025; CI</italic>): 1.07 (0.28, 1.86), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.008] (<xref ref-type="fig" rid="F7">Figure&#x00A0;7A</xref>). The funnel plot appeared symmetrical, suggesting a low risk of publication bias (<xref ref-type="fig" rid="F7">Figure&#x00A0;7B</xref>). The subgroup analysis of the WBC outcome stratified by age range demonstrated that, in the &#x2265;12 years subgroup, the WBC levels in the RMPP group remained significantly higher than those in the NRMPP group under the random effects model, whereas in the &#x003C;12 years subgroup, the results from the random effects model were unstable due to high heterogeneity. Additionally, age exerted a significant modifying effect on the WBC response under the fixed effects model, with more prominent differences observed in the &#x2265;12 years subgroup. (<xref ref-type="sec" rid="s11">Supplementary Figure S3</xref>).</p>
<fig id="F7" position="float"><label>Figure 7</label>
<caption><p><bold>(A)</bold> Estimated MD summary for WBC. <bold>(B)</bold> Funnel plot for publication bias risk of WBC.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g007.tif"><alt-text content-type="machine-generated">Forest plot and funnel plot from a meta-analysis. The forest plot on the left shows individual study mean differences with confidence intervals comparing experimental and control groups, with an overall mean difference shown in a diamond. Heterogeneity statistics are included. The funnel plot on the right displays distribution symmetry of studies&#x2019; standard error against mean difference, indicating possible publication bias.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c7"><label>3.3.7</label><title>Neutrophils (&#x0025;)</title>
<p>Eight articles (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B36">36</xref>) were combined to analyze Neutrophils (&#x0025;), including 2,364 cases. The heterogeneity test after merging was statistically signi&#xFB01;cant (<italic>I</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;97&#x0025;). The results found that the Neutrophils (&#x0025;) of the RMPP group were significantly higher than those of the NRMPP group, and the difference was statistically significant [<italic>MD</italic> (<italic>95&#x0025;CI</italic>): 9.27 (3.45, 15.09), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.002] (<xref ref-type="fig" rid="F8">Figure&#x00A0;8</xref>).</p>
<fig id="F8" position="float"><label>Figure 8</label>
<caption><p>Estimated MD summary for neutrophils (&#x0025;).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g008.tif"><alt-text content-type="machine-generated">Forest plot showing the mean differences between experimental and control groups across eight studies. Each study lists mean, standard deviation, and total for both groups. The overall mean difference is 9.27 with a confidence interval of 3.45 to 15.09. Heterogeneity statistics include Tau squared of 64.92, Chi squared of 241.45, and an I squared of 97 percent. The test for overall effect shows Z equals 3.12 with a p-value of 0.002. The plot indicates a general favor towards the experimental group.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c8"><label>3.3.8</label><title>Fever duration (days)</title>
<p>Six articles (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>) were merged to analyze the duration of fever, including 1,441 cases. Heterogeneity tests after merging showed poor homogeneity in the included literature (<italic>I</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;91&#x0025;). Finally, the random effects model was adopted. The study suggested that the duration of fever in the RMPP group was longer than that in the NRMPP group, and the difference was statistically significant [<italic>MD</italic> (<italic>95&#x0025; CI</italic>): 4.36 (2.66, 6.06), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001], as shown in <xref ref-type="fig" rid="F9">Figure&#x00A0;9</xref>.</p>
<fig id="F9" position="float"><label>Figure 9</label>
<caption><p>Estimated MD summary for fever duration (days).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g009.tif"><alt-text content-type="machine-generated">Forest plot showing the mean difference in various studies comparing experimental and control groups. Includes studies by Shen, Wen, Yao, Zhai, Zhan, and Zhang from 2016 to 2023. The mean differences and confidence intervals are listed, with a summarized effect size of 4.36 favoring the experimental group. Notable heterogeneity is indicated, with I2 at 91 percent.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c9"><label>3.3.9</label><title>AST</title>
<p>After using a random effects model to summarize the AST levels of 5 studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>), it was found that the AST levels in the RMPP group were significantly higher than those in the NRMPP group [<italic>MD</italic> (<italic>95&#x0025; CI</italic>): 16.11 (8.21, 24.01), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001], as shown in <xref ref-type="fig" rid="F10">Figure&#x00A0;10</xref>.</p>
<fig id="F10" position="float"><label>Figure 10</label>
<caption><p>Estimated MD summary for AST.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g010.tif"><alt-text content-type="machine-generated">Forest plot showing a meta-analysis of five studies comparing experimental and control groups. Each study lists mean, standard deviation, total participants, and weight. Mean differences with ninety-five percent confidence intervals are shown as green squares with lines. The overall effect is depicted as a diamond, indicating a mean difference of 16.11 [8.21, 24.01]. Heterogeneity is indicated with Tau2&#x003D;67.83, Chi2&#x003D;29.01, df&#x003D;4, P &#x003C; 0.00001; I2&#x003D; 86&#x0025;. Test for overall effect: Z&#x003D;4.00, P &#x003C; 0.0001.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c10"><label>3.3.10</label><title>ALT</title>
<p>Four studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B23">23</xref>) were combined and analyzed for ALT, including 1,529 cases. The analysis indicated that the ALT levels in the RMPP group were significantly higher than those in the NRMPP group [<italic>MD</italic> (<italic>95&#x0025; CI</italic>): 23.69 (9.60, 37.77), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.001] (<xref ref-type="fig" rid="F11">Figure&#x00A0;11</xref>).</p>
<fig id="F11" position="float"><label>Figure 11</label>
<caption><p>Estimated MD summary for ALT.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g011.tif"><alt-text content-type="machine-generated">Forest plot illustrating the mean differences in studies by Huang 2021, Lu 2014, Wang 2015, and Wen 2021. The differences range from 3.00 to 47.40, with a total mean difference of 23.69. The plot includes confidence intervals, favoring the experimental group. Heterogeneity measures are indicated, with high variability (I2&#x003D; 97&#x0025;). Statistical significance is noted with P &#x003C; 0.00001.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c11"><label>3.3.11</label><title>IL-6</title>
<p>Four studies (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B35">35</xref>) reported IL-6 levels, with heterogeneity results showing <italic>I</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;63&#x0025;. Meta-analysis showed that IL-6 levels in the RMPP group were significantly higher than those in the NRMPP group [<italic>MD</italic> (<italic>95&#x0025; CI</italic>): 23.07 (20.90, 25.24), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.0001] (<xref ref-type="fig" rid="F12">Figure&#x00A0;12</xref>).</p>
<fig id="F12" position="float"><label>Figure 12</label>
<caption><p>Estimated MD summary for IL-6.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g012.tif"><alt-text content-type="machine-generated">Forest plot showing meta-analysis of four studies comparing experimental and control groups. Each study displays mean differences and ninety-five percent confidence intervals, favoring the experimental group. Heterogeneity indices are Tau-squared equals 2.69; Chi-squared equals 8.08; I-squared equals 63 percent; overall effect Z equals 20.86 with P less than 0.00001.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c12"><label>3.3.12</label><title>ESR</title>
<p>A total of 4 studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>) were combined to analyze ESR, including 1,640 patients. Heterogeneity tests showed an <italic>I</italic><sup>2</sup> of 57&#x0025;, and meta-analysis results showed that the ESR of the RMPP group was higher than that of the NRMPP group [<italic>MD</italic> (<italic>95&#x0025; CI</italic>): 10.93 (7.75, 14.11), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001], as shown in <xref ref-type="fig" rid="F13">Figure&#x00A0;13</xref>.</p>
<fig id="F13" position="float"><label>Figure 13</label>
<caption><p>Estimated MD summary for ESR.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g013.tif"><alt-text content-type="machine-generated">Forest plot displaying four studies comparing experimental and control groups. Each study, represented by a green square, shows mean differences with 95&#x0025; confidence intervals. Overall mean difference is 10.93, favoring the experimental group. Heterogeneity statistics: Tau-squared is 5.75, Chi-squared is 6.97 with 3 degrees of freedom, P-value is 0.07, and I-squared is 57&#x0025;. Test for overall effect shows Z-value of 6.74 with P-value less than 0.00001.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c13"><label>3.3.13</label><title>Combined pleural effusion</title>
<p>A total of 10 articles (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B19">19</xref>&#x2013;<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>) were analyzed, including 2,658 cases, with heterogeneity testing indicated an <italic>I</italic><sup>2</sup> of 86&#x0025;. Therefore, the results of the random effects model indicated that the combined pleural effusion in the RMPP group was higher than that in the NRMPP group, and the difference was statistically significant [<italic>OR</italic> (<italic>95&#x0025; CI</italic>): 7.59 (4.19, 13.75), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.0001] as shown in the figure (<xref ref-type="fig" rid="F14">Figure&#x00A0;14A</xref>). The funnel plot indicated potential publication bias, with data points being asymmetrically distributed around the center line, suggesting that studies with higher odds ratios were more likely to be published (<xref ref-type="fig" rid="F14">Figure&#x00A0;14B</xref>).</p>
<fig id="F14" position="float"><label>Figure 14</label>
<caption><p><bold>(A)</bold> Estimated OR summary for combined pleural effusion. <bold>(B)</bold> Funnel plot for publication bias risk of combined pleural effusion.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g014.tif"><alt-text content-type="machine-generated">A forest plot and funnel plot are shown. The forest plot on the left displays studies comparing experimental versus control events with odds ratios and 95&#x0025; confidence intervals. It indicates a total odds ratio of 7.59, favoring experimental. The funnel plot on the right assesses publication bias with data points scattered around the center line, suggesting asymmetry.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c14"><label>3.3.14</label><title>Lung consolidation</title>
<p>A total of 8 studies (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>) reported the relationship between lung consolidation and RMPP, including 1,896 patients. The heterogeneity results were statistically significant (<italic>I</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;90&#x0025;). Meta-analysis showed that lung consolidation was a risk factor for RMPP in children[<italic>OR</italic> (<italic>95&#x0025; CI</italic>): 10.61 (4.13, 27.26), <italic>P</italic>&#x2009;&#x003C;&#x2009;0.0001], as shown in <xref ref-type="fig" rid="F15">Figure&#x00A0;15</xref>.</p>
<fig id="F15" position="float"><label>Figure 15</label>
<caption><p>Estimated OR summary for lung consolidation.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-13-1512689-g015.tif"><alt-text content-type="machine-generated">Forest plot displaying odds ratios and confidence intervals for eight studies comparing experimental vs. control events. The studies include Fu 2022, Gao 2023, Guo 2019, and others. Odds ratios range from 1.15 to 597.43. The overall effect shows a significant difference favoring the experimental group, with an odds ratio of 10.61 and the confidence interval from 4.13 to 27.26. The diamond at the bottom visualizes the pooled effect estimate.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s3d"><label>3.4</label><title>Sensitivity analysis</title>
<p>Sensitivity analysis was performed on factors with high heterogeneity through leave-one-out method. Results showed that heterogeneity for ESR, Fever duration, and Lung Consolidation was reduced after respectively removing studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B33">33</xref>). However, heterogeneity for LDH, WBC, IL-6, AST, ALT, Neutrophils (&#x0025;), CRP, and Combined pleural effusion remained largely unchanged. These findings indicated the stability and high credibility of the results. The detailed results of the sensitivity analysis are presented in <xref ref-type="sec" rid="s11">Supplementary Table S3</xref>.</p>
</sec>
<sec id="s3e"><label>3.5</label><title>Publication bias</title>
<p>Egger test was used to evaluate publication bias. The results indicated that WBC AST, ALT, CRP, IL-6, ESR, the duration of fever, and pleural effusion showed no significant publication bias, while LDH, neutrophil percentage, and lung consolidation showed evidence of publication bias (<xref ref-type="sec" rid="s11">Supplementary Table S4</xref>). The Trim and Fill analysis indicated that for studies related to LDH, Neutrophil Percentage, and Pulmonary Consolidation, there was a low risk of publication bias. The effect sizes remained unchanged after adjustment, and the original results demonstrated high robustness, being not significantly affected by publication bias (<xref ref-type="sec" rid="s11">Supplementary Figures S4&#x2013;S6</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<p>To our knowledge, mycoplasma infection was an important component of community-acquired pneumonia in children, with an infection rate of 40&#x0025; and a mortality rate of 1.38&#x0025; (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B27">27</xref>) during the epidemic. With the widespread use of macrolide antibiotics in recent years, the antibiotic resistance rate of <italic>M. pneumoniae</italic> had been rising, and the incidence rate of RMPP had also been increasing, especially in Asian countries (<xref ref-type="bibr" rid="B38">38</xref>&#x2013;<xref ref-type="bibr" rid="B40">40</xref>). Children with RMPP could develop complications such as pleural effusion, bronchiectasis, and bronchiolitis obliterans, and their prognosis was often poor. Therefore, early identification and treatment of RMPP were extremely important for pediatricians (<xref ref-type="bibr" rid="B41">41</xref>). This study included a total of 28 articles, including 6,374 cases, which included a wider range of indicators compared to previous studies. These indicators included inflammatory factors and other features such as CRP, LDH, ESR, WBC, IL-6, neutrophil count (&#x0025;), AST, ALT, duration of fever, lung consolidation, and pleural effusion.</p>
<p>The immune response to <italic>M. pneumoniae</italic>e infection played a pivotal role in the manifestation of clinical symptoms. CRP, ESR, LDH, and neutrophil count (&#x0025;) were non-specific indicators of inflammatory response. CRP was an acute phase protein synthesized by liver cells when the body was subjected to inflammatory stimuli such as microbial invasion or tissue damage (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B33">33</xref>). CRP increased several hours after the onset of inflammation and reached its peak within 48&#x2005;h. The increase in CRP value lagged behind the change in inflammatory activity by about 12&#x2005;h; however, it was important to detected earlier than clinical symptoms (<xref ref-type="bibr" rid="B23">23</xref>). LDH was an important enzyme that catalyzed the oxidation-reduction reaction between lactate and pyruvate in glycolysis and gluconeogenesis processes. It had highly sensitivity, and even mild tissue damage could cause changes in serum LDH levels. Therefore, LDH was an important factor reflecting the degree of tissue damage and disease (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). After comprehensive analysis, we found that the levels of CRP and LDH in the RMPP group were significantly higher than those in the NRMPP group, which was consistent with previous studies (<xref ref-type="bibr" rid="B41">41</xref>). However, there were contradictions in current research regarding ESR, as studies showed that ESR was a risk factor for the development of RMPP (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B23">23</xref>). While, some meta-analyses also found no difference in ESR between the two groups [MD (95&#x0025; CI): 8.11 (&#x2212;1.34,17.56), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.09] (<xref ref-type="bibr" rid="B11">11</xref>). Our analysis once again confirmed that ESR was a risk factor for RMPP. Unlike CRP, ESR responded more slowly, typically becoming evident 2&#x2013;3 days after the onset of the inflammatory response, and serves as a key marker for evaluating inflammatory reactions and disease activity (<xref ref-type="bibr" rid="B23">23</xref>). Study demonstrated that <italic>M. pneumoniae</italic>e infection of bronchial epithelial cells <italic>in vitro</italic> significantly altered cellular metabolism, characterized by increased glucose uptake, enhanced aerobic glycolysis, and augmented ATP synthesis. The synthesized ATP was released into the extracellular environment through vesicular exocytosis and pannexin channels, resulting in a marked increase in extracellular ATP levels. This elevated extracellular ATP interacted with cell surface receptors, activating inflammation&#x2014;related signaling pathways such as P2X and P2Y receptors, leading to the release of inflammatory mediators and thus intensifying the inflammatory response (<xref ref-type="bibr" rid="B2">2</xref>). As the subgroup analysis suggested, older children, due to their relatively mature and overactive immune systems, were more prone to developing RMPP, a finding that was consistent with some reports (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>In clinical practice, we found that the WBC in children with <italic>M. pneumoniae</italic> infection was often within the normal range. Therefore, few pediatricians paid attention to the WBC in RMPP. Fortunately, through meta-analysis, we found that the WBC in the RMPP group was slightly higher than that in the NRMPP group [MD (95&#x0025; CI): 1.15 (0.33, 1.97), <italic>P</italic>&#x2009;&#x003D;&#x2009;0.006]; This had rarely been mentioned in previous meta-analyses. The immune system generated a strong immune response during infection or inflammation, leading to an increase in WBC to counter potential threats (<xref ref-type="bibr" rid="B36">36</xref>). Our study also summarized the levels of AST, and ALT levels, which were rarely mentioned in previous meta-analyses. Some studies had also shown that multi-organ dysfunction was more severe in the RMPP group, especially liver dysfunction (<xref ref-type="bibr" rid="B18">18</xref>). Mycoplasmas possessed an array of virulence factors that enabled them to overcome numerous barriers and successfully invade the host&#x0027;s defenses. They achieved adhesion by binding to host cell receptors or the extracellular matrix via ligand proteins. During proliferation, mycoplasmas absorbed nutrients from host cells and released various metabolic byproducts, including hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), ammonia (NH<sub>3</sub>), and hydrogen sulfide (H<sub>2</sub>S), which caused local tissue damage (<xref ref-type="bibr" rid="B1">1</xref>). It should be noted that only four studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B23">23</xref>) reported this, which limited its generalizability. After human were infected with pathogens, the occurrence and development of inflammation are mainly the result of the interaction between pro-inflammatory and anti-inflammatory cytokines. The body produced pro-inflammatory factors such as IL-6, TNF-&#x03B1;, and IFN-&#x03B3; to drive away pathogens (<xref ref-type="bibr" rid="B13">13</xref>). Mycoplasmas may have secreted various exotoxins, such as hemolysins, and expressed multiple pathogenic enzymes. These enzymes, which included lipolytic enzymes, peptidases, phosphatases, ecto-ATPases, cytotoxic nucleases, and nucleotidases, contributed significantly to the toxicity affecting host cells. Additionally, some inherent components of mycoplasmas, like lipids, membrane lipoproteins, and even superantigens, could have had a considerable pathogenic impact on host cells or the immune system (<xref ref-type="bibr" rid="B1">1</xref>).</p>
<p>Studies indicated that RMPP had a longer fever duration, severe clinical symptoms, rapid progression of signs, often with large areas of lung involvement in a short period, prone to pleural effusion and atelectasis, prolonged course, poor response to macrolide antibiotics, and some cases were accompanied by systemic inflammatory response syndrome or severe extrapulmonary complications, and might even develop into severe pneumonia such as necrotizing pneumonia (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). Study indicated that a fever lasting for more than 10 days was a risk factor for RMPP (<xref ref-type="bibr" rid="B46">46</xref>). In our study, the incidence of large-scale lung consolidation and pleural effusion in the RMPP group was significantly higher than that in NRMPP group, which was consistent with previous research. This may have been related to the increased permeability of alveolar and pleural capillaries caused by pulmonary infections and systemic inflammatory responses. The risk of pulmonary consolidation and pleural effusion in the RMPP group was significantly higher than that in the NRMPP group in our study. Some scholars proposed that if a patient experienced fever duration for over 7 days, CRP &#x003E;110&#x2005;mg/L, LDH&#x2009;&#x003E;&#x2009;478&#x2005;U/L, and showed lung consolidation, it may have indicated the development of RMPP (<xref ref-type="bibr" rid="B45">45</xref>). This might have been related to the increased permeability of alveolar and pleural capillaries caused by pulmonary infections and systemic inflammatory responses. Small molecular proteins permeated the infected lung tissue through the alveolar capillary wall, and the exudate of proteinous edema fluid rapidly spreads through the alveoli, forming pulmonary consolidation. Extensive pulmonary consolidation involving the pleura led to a large amount of inflammatory pleural exudate (<xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>In this study, except for the study by Xu D et al. (<xref ref-type="bibr" rid="B25">25</xref>), all other included studies were retrospective. They analyzed existing data, which might have been incomplete or inaccurately recorded, leading to the risk of incomplete predictors or the potential for ignoring predictors due to data deficiencies. Additionally, retrospective studies assessed outcomes after they had occurred, making the causal relationship between predictors and outcomes more uncertain. Furthermore, all studies included had used conventional logistic regression, which has limitations in model assumptions, high data demands, and weak handling of interactions and non-linear relationships. In contrast, prospective studies collect data and measure predictors before outcomes occur. This enhances model accuracy and reliability, and improves data integrity and consistency, effectively reducing bias risks. With the development of machine learning in the medical field, algorithms such as decision trees, support vector machines, and random forests have been applied to the construction of prediction models (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). It is suggested that future research on pediatric RMPP risk prediction models should adopt prospective study methods, integrate machine learning techniques, and use large sample sizes to develop models with good risk performance and strong stability.</p>
<p>The limitations of this study were: (1) All participants in the study were from China, which might have impacted the extrapolation of the conclusions; (2) some exposure factors with high diagnostic value for RMPP (such as D-dimers, etc.) could not be processed and combined due to a lack of original studies; (3) The included studies were all case&#x2014;control studies. This design limited the research depth and made various potential biases unavo- idable. (4) This meta- analysis used the Newcastle-Ottawa Scale (NOS) to assess study quality, which, while widely used, lacks the comprehensive bias assessment provided by tools like ROBINS-E. This may limit the detection of subtle biases, potentially affecting the robustness of our findings. Future research should consider using more detailed bias assessment tools to enhance the reliability of meta-analytic results.</p>
</sec>
<sec id="s5" sec-type="conclusions"><label>5</label><title>Conclusions</title>
<p>In summary, the longer the fever duration in children, the more pronounced the increase in IL-6, CRP, LDH, ESR, and neutrophil (&#x0025;), the more severe the liver function damage, and the more serious the pleural effusion, the more extensive the involvement of large areas of lung consolidation, and the more likely it was to complicate refractory <italic>M. pneumoniae</italic> pneumonia in children.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability"><title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>CC: Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. SC: Resources, Writing &#x2013; review &#x0026; editing. CY: Funding acquisition, Writing &#x2013; review &#x0026; editing. XZ: Investigation, Writing &#x2013; original draft. LL: Methodology, Writing &#x2013; review &#x0026; editing. YW: Supervision, Validation, Writing &#x2013; review &#x0026; editing. MC: Supervision, Validation, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. Supported by Sanming Project of Medicine in Shenzhen (No. SZSM202211001).</p>
</sec>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s12" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material"><title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fped.2025.1512689/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fped.2025.1512689/full&#x0023;supplementary-material</ext-link></p>
<supplementary-material id="SD1" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="Supplementaryfile1.docx"/></supplementary-material>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Wu</surname><given-names>YY</given-names></name><name><surname>Qin</surname><given-names>LM</given-names></name><name><surname>Zhu</surname><given-names>CM</given-names></name><name><surname>You</surname><given-names>XX</given-names></name></person-group>. <article-title>Infection strategies of mycoplasmas: unraveling the panoply of virulence factors</article-title>. <source>Virulence</source>. (<year>2021</year>) <volume>12</volume>(<issue>1</issue>):<fpage>788</fpage>&#x2013;<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1080/21505594.2021.1889813</pub-id><pub-id pub-id-type="pmid">33704021</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J</given-names></name><name><surname>Xiu</surname><given-names>FC</given-names></name><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>HW</given-names></name><name><surname>Xi</surname><given-names>YX</given-names></name><etal/></person-group> <article-title>Aerobic glycolysis of bronchial epithelial cells rewires <italic>M. pneumoniae</italic> pneumonia and promotes bacterial elimination</article-title>. <source>Infect Immun</source>. (<year>2024</year>) <volume>92</volume>(<issue>2</issue>):<fpage>e002</fpage>&#x2013;<lpage>4823</lpage>. <pub-id pub-id-type="doi">10.1128/iai.00248-23</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name></person-group>. <article-title>Insight into the pathogenic mechanism of Mycoplasma pneumoniae</article-title>. <source>Curr Microbiol</source>. (<year>2022</year>) <volume>80</volume>(<issue>1</issue>):<fpage>14</fpage>. <pub-id pub-id-type="doi">10.1007/s00284-022-03103-0</pub-id><pub-id pub-id-type="pmid">36459213</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Gong</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Lei</surname><given-names>A</given-names></name></person-group>. <article-title>Biological functions of IL-17-producing cells in mycoplasma respiratory infection</article-title>. <source>Immunology</source>. (<year>2021</year>) <volume>164</volume>(<issue>2</issue>):<fpage>223</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1111/imm.13346</pub-id><pub-id pub-id-type="pmid">33930194</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><collab>National Health Commission of the People&#x2019;s Republic of China</collab>. <article-title>Guidelines for the diagnosis and treatment of <italic>M. pneumoniae</italic> pneumonia in children (2023 edition)</article-title>. <source>J Int J Epidemiol</source>. (<year>2023</year>) <volume>50</volume>(<issue>2</issue>):<fpage>79</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.cn331340-20230217-00023</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>T-B cell epitope peptides induce protective immunity against mycopla- sma pneumoniae respiratory tract infection in BALB/c mice</article-title>. <source>Immunobiology</source>. (<year>2021</year>) <volume>226</volume>(<issue>3</issue>):<fpage>152077</fpage>. <pub-id pub-id-type="doi">10.1016/j.imbio.2021.152077</pub-id><pub-id pub-id-type="pmid">33831654</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Ge</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>B</given-names></name></person-group>. <article-title>Research status and challenges of <italic>M. pneumoniae</italic> pneumonia in children: a bibliometric and visualization analysis from 2011 to 2023</article-title>. <source>Medicine</source>. (<year>2024</year>) <volume>103</volume>(<issue>11</issue>):<fpage>e375</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000037521</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>LL</given-names></name><name><surname>Zhuang</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>JF</given-names></name><etal/></person-group> <article-title>The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Sci Rep</source>. (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>2059</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-81853-w</pub-id><pub-id pub-id-type="pmid">33479472</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name></person-group>. <article-title>Clinical significance of D-dimer levels in refractory <italic>M. pneumoniae</italic> pneumonia</article-title>. <source>BMC Infect Dis</source>. (<year>2021</year>) <volume>21</volume>(<issue>1</issue>):<fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-020-05700-5</pub-id><pub-id pub-id-type="pmid">33407216</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><etal/></person-group> <article-title>Risk factors for refractory m ycoplasm a pneum oniae pneum onia in children: a systematic review</article-title>. <source>Chin J Evid Based Med</source>. (<year>2021</year>) <volume>21</volume>(<issue>10</issue>):<fpage>1168</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.7507/1672-2531.202106161</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>Q</given-names></name></person-group>. <article-title>Refractory <italic>M. pneumoniae</italic> in children: a systematic review and meta-analysis of laboratory features and predictors</article-title>. <source>J Immunol Res</source>. (<year>2022</year>) <volume>202</volume>(<issue>2</issue>):<fpage>9227838</fpage>. <pub-id pub-id-type="doi">10.1155/2022/9227838</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>XX</given-names></name><name><surname>Lin</surname><given-names>JL</given-names></name><name><surname>Dai</surname><given-names>JK</given-names></name></person-group>. <article-title>Value of lactate dehydrogenase in predicting refractory <italic>M. Pneumoniae</italic>e pneumonia in children: an evaluation based on decision curve analysis and doseresponse analysis</article-title>. <source>Chin J Contemp Pediatr</source>. (<year>2020</year>) <volume>22</volume>(<issue>2</issue>):<fpage>112</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.7499/j.issn.1008-8830.2020.02.006</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>JY</given-names></name><name><surname>Lin</surname><given-names>LJ</given-names></name><name><surname>Mai</surname><given-names>LJ</given-names></name><name><surname>Fu</surname><given-names>XX</given-names></name><name><surname>Su</surname><given-names>XD</given-names></name></person-group>. <article-title>Clinical characteristics and risk factors of refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>J Clin Pediatr</source>. (<year>2017</year>) <volume>35</volume>(<issue>8</issue>):<fpage>569</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1000-3606.2017.08.003</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>YN</given-names></name><name><surname>Hao</surname><given-names>MM</given-names></name><name><surname>Yin</surname><given-names>ZR</given-names></name></person-group>. <article-title>Expression of serum ferritin and lactate dehydrogenase in peripheral blood of children with refractory <italic>M. pneumoniae</italic> and the correlation with prognosis</article-title>. <source>Chin J Exp Clin Infect Dis</source>. (<year>2020</year>) <volume>14</volume>(<issue>2</issue>):<fpage>133</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3877/cma.j.issn.1674-1358.2020.02.009</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>HH</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group>. <article-title>Blood routine, immunoglobulin, D-dexpression and their efficiency of predicting the risk of plastic bronchitis in children with RMPP</article-title>. <source>J Hebei Med Univ</source>. (<year>2021</year>) <volume>42</volume>(<issue>8</issue>):<fpage>914</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3969/ji.ssn.1007-3205.2021.08.011</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>YZ</given-names></name><name><surname>Zhou</surname><given-names>KY</given-names></name></person-group>. <article-title>The significace of lactate dehydrogenase in the diagnosis and treatment of children with refractory <italic>M. pneumoniae</italic> pneumonia</article-title>. <source>Chin Pediatr Emerg Med</source>. (<year>2017</year>) <volume>24</volume>(<issue>4</issue>):<fpage>305</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.1673-4912.2017.04.015</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Fu</surname><given-names>JP</given-names></name><name><surname>Zhang</surname><given-names>GP</given-names></name><name><surname>Nie</surname><given-names>W</given-names></name><name><surname>Xiang</surname><given-names>SZ</given-names></name></person-group>. <article-title>Expression levels and significance of peripheral blood TIM-3 and its ligand galectin-9 in children with refractory <italic>M. pneumoniae</italic> pneumonia</article-title>. <source>J Southeast Univ</source>. (<year>2023</year>) <volume>42</volume>(<issue>2</issue>):<fpage>234</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1671-6264.2023.02.009</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>AZ</given-names></name><name><surname>Yang</surname><given-names>HW</given-names></name><name><surname>Wang</surname><given-names>CK</given-names></name><name><surname>Qian</surname><given-names>LL</given-names></name><name><surname>Zhang</surname><given-names>XB</given-names></name><name><surname>Wang</surname><given-names>LB</given-names></name></person-group>. <article-title>The associated factors of refractory <italic>M. pneumoniae</italic> pneumonia in hospitalized children in a mono-center in Shanghai</article-title>. <source>Chin J Evid Based Pediatr</source>. (<year>2014</year>) <volume>9</volume>(<issue>6</issue>):<fpage>411</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1673-5501.2014.06.003</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>YF</given-names></name><name><surname>Chen</surname><given-names>JM</given-names></name><name><surname>Duan</surname><given-names>MY</given-names></name><name><surname>Wu</surname><given-names>WD</given-names></name></person-group>. <article-title>Early prediction of inflammatory indexes on refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Chin J Obstet Gynecol Pediatr</source>. (<year>2021</year>) <volume>17</volume>(<issue>2</issue>):<fpage>207</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.3877/cma.j.issn.1673-5250.2021.02.012</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>LL</given-names></name><name><surname>Huang</surname><given-names>DP</given-names></name><name><surname>Lu</surname><given-names>LL</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>SM</given-names></name></person-group>. <article-title>Value of chitinase-like protein YKL-40 in bronchoalveolar lavage ffuid for predicting refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Chin J Contemp Pediatr</source>. (<year>2021</year>) <volume>23</volume>(<issue>5</issue>):<fpage>471</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.7499/j.issn.1008-8830.2012095</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>BB</given-names></name><name><surname>Zhong</surname><given-names>LL</given-names></name><name><surname>Ye</surname><given-names>TT</given-names></name><name><surname>Han</surname><given-names>YM</given-names></name><name><surname>Qiu</surname><given-names>XC</given-names></name></person-group>. <article-title>Value of autotaxin in predicting refractory <italic>M. pneumoniae</italic> pneumonia in children and its correlation with inflammatory cytokines</article-title>. <source>Chin J Contemp Pediatr</source>. (<year>2022</year>) <volume>24</volume>(<issue>7</issue>):<fpage>765</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.7499/j.issn.1008-8830.2203030</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>YM</given-names></name><name><surname>Xu</surname><given-names>MX</given-names></name></person-group>. <article-title>Changes and clinical significances of serum apolipoprotein C1 and YKL-40 levels in children with refractory <italic>M. pneumoniae</italic> pneumonia</article-title>. <source>J Chin Pract Diagn Ther</source>. (<year>2020</year>) <volume>34</volume>(<issue>6</issue>):<fpage>592</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.13507/j.issn.1674-3474.2020.06.014</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>YC</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name></person-group>. <article-title>Early identiffcation of refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Chin J Contemp Pediatr</source>. (<year>2015</year>) <volume>17</volume>(<issue>11</issue>):<fpage>1189</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.7499/j.issn.1008-8830.2015.11.008</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>ZH</given-names></name><name><surname>Zhang</surname><given-names>HZ</given-names></name><name><surname>Kan</surname><given-names>FY</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group>. <article-title>Expression of peripheral blood TLR2 signaling pathway in children with refractory <italic>M. pneumoniae</italic> and its diagnostic value for curative effect</article-title>. <source>Chin J Nosocom</source>. (<year>2023</year>) <volume>33</volume>(<issue>4</issue>):<fpage>613</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.11816/cn.ni.2023-220796</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>AL</given-names></name><name><surname>Zheng</surname><given-names>JS</given-names></name><name><surname>Ye</surname><given-names>MW</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Qian</surname><given-names>GC</given-names></name><etal/></person-group> <article-title>A multicenter prospective study on early identif- ication of refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Chin J Pediatr</source>. (<year>2024</year>) <volume>62</volume>(<issue>4</issue>):<fpage>317</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.cn112140-20231121-00383</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>HS</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>LY</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ying</surname><given-names>LL</given-names></name><name><surname>Han</surname><given-names>XH</given-names></name></person-group>. <article-title>Correlation of <italic>M. pneumoniae</italic> resistance gene detection and refractory <italic>M. pneumoniae</italic> pneumonia</article-title>. <source>Int J Pediatr</source>. (<year>2016</year>) <volume>43</volume>(<issue>6</issue>):<fpage>492</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.1673-4408.2016.06.017</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>LF</given-names></name><name><surname>Zhang</surname><given-names>JL</given-names></name><name><surname>Wu</surname><given-names>XJ</given-names></name><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Duan</surname><given-names>CC</given-names></name><name><surname>Kang</surname><given-names>JC</given-names></name><etal/></person-group> <article-title>Predictive role of IL-17 A in refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>J Clin Pediatr</source>. (<year>2023</year>) <volume>41</volume>(<issue>5</issue>):<fpage>366</fpage>&#x2013;<lpage>9</lpage>, <comment>375</comment>. <pub-id pub-id-type="doi">10.12372/jcp.202322e0032</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>TT</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>LM</given-names></name></person-group>. <article-title>Clinical features and biomarkers for early prediction of refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Emerg Med Int</source> (<year>2024</year>) <volume>2024</volume>:<fpage>9328177</fpage>. <pub-id pub-id-type="doi">10.1155/2024/932817-7</pub-id><pub-id pub-id-type="pmid">38222094</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>F</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Development of a nomogram for predicting refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Front Pediatr</source>. (<year>2022</year>) <volume>10</volume>:<fpage>813614</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2022.813614</pub-id><pub-id pub-id-type="pmid">35281240</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>WH</given-names></name><name><surname>Zhou</surname><given-names>MP</given-names></name><name><surname>Zou</surname><given-names>YY</given-names></name><name><surname>Chen</surname><given-names>JW</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><etal/></person-group> <article-title>The predictive values of soluble B7-DC in children with refractory <italic>M. pneumoniae</italic> pneumonia</article-title>. <source>Transl Pediatr</source>. (<year>2023</year>) <volume>12</volume>(<issue>3</issue>):<fpage>396</fpage>&#x2013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.21037/tp-23-86</pub-id><pub-id pub-id-type="pmid">37035403</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>SS</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>SH</given-names></name><name><surname>Shi</surname><given-names>SJ</given-names></name><etal/></person-group> <article-title>Recognition of refractory <italic>M. pneumoniae</italic> pneumonia among myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model</article-title>. <source>BMC Pulm Med</source>. (<year>2023</year>) <volume>23</volume>(<issue>1</issue>):<fpage>383</fpage>. <pub-id pub-id-type="doi">10.1186/s12890-023-02684-1</pub-id><pub-id pub-id-type="pmid">37817172</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>XH</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>LN</given-names></name></person-group>. <article-title>Observational retrospective clinical study on clinical features of macrolide-resistant <italic>M. pneumoniae</italic> pneumonia in Chinese pediatric cases</article-title>. <source>Sci Rep</source>. (<year>2024</year>) <volume>14</volume>(<issue>1</issue>):<fpage>5632</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-55311-2</pub-id><pub-id pub-id-type="pmid">38453960</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Na</surname><given-names>L</given-names></name><name><surname>Mu</surname><given-names>YP</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group>. <article-title>Value of absolute counts of lymphocyte subsets in the early prediction of refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Chin J Contemp Pediatr</source>. (<year>2019</year>) <volume>21</volume>(<issue>6</issue>):<fpage>511</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.7499/j.is-sn.1008-8830.2019.06.003</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JR</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>HM</given-names></name><name><surname>Li</surname><given-names>HM</given-names></name><name><surname>Zhao</surname><given-names>SY</given-names></name><name><surname>Jiang</surname><given-names>ZF</given-names></name></person-group>. <article-title>Clinical characteristics and predictive factors of refractory <italic>M. pneumoniae</italic> pneumonia</article-title>. <source>Chin J Pediatr</source>. (<year>2012</year>) <volume>50</volume>(<issue>12</issue>):<fpage>915</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.0578-1310.2012.12.010</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>YX</given-names></name><name><surname>Feng</surname><given-names>YF</given-names></name><name><surname>Shen</surname><given-names>DH</given-names></name><name><surname>Wang</surname><given-names>ML</given-names></name><name><surname>Yang</surname><given-names>XP</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Analysis on the vitamin A level and immune function in children with common and refractory <italic>M. pneumoniae</italic> pneumonia</article-title>. <source>J Guangxi Med Univ</source>. (<year>2019</year>) <volume>36</volume>(<issue>1</issue>):<fpage>23</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.16190/j.cnki.45-1211/r.2019.01.006</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>XH</given-names></name><name><surname>Li</surname><given-names>QQ</given-names></name><name><surname>Xiang</surname><given-names>ZW</given-names></name><name><surname>Luo</surname><given-names>YF</given-names></name><name><surname>An</surname><given-names>YQ</given-names></name></person-group>. <article-title>Clinical features and treatment of refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>J Clin Pediatr</source>. (<year>2015</year>) <volume>33</volume>(<issue>11</issue>):<fpage>958</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1000-3606.11.010</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>GD</given-names></name><name><surname>Peng</surname><given-names>XQ</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name><name><surname>Qu</surname><given-names>CX</given-names></name><name><surname>Zhang</surname><given-names>ZK</given-names></name></person-group>. <article-title>Application of neutrophil/lymphocyte ratio in the diagnosis and prediction of refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>J Xuzhou Med Univ</source>. (<year>2022</year>) <volume>42</volume>(<issue>9</issue>):<fpage>672</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.2096-3882.2022.09.010</pub-id></citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waites</surname><given-names>KB</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Balish</surname><given-names>MF</given-names></name><name><surname>Atkinson</surname><given-names>TP</given-names></name></person-group>. <article-title><italic>M. pneumoniae</italic> from the respiratory tract and beyond</article-title>. <source>Clin Microbiol Rev</source>. (<year>2017</year>) <volume>30</volume>(<issue>3</issue>):<fpage>747</fpage>&#x2013;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00114-16</pub-id><pub-id pub-id-type="pmid">28539503</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Chung</surname><given-names>EH</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>HB</given-names></name><etal/></person-group> <article-title>Clinical characteristics of macroliderefractory <italic>M. pneumoniae</italic> pneumonia in Korean children: a multicenter retrospective study</article-title>. <source>J Clin Med</source>. (<year>2022</year>) <volume>11</volume>(<issue>2</issue>):<fpage>306</fpage>. <pub-id pub-id-type="doi">10.3390/jcm11020306</pub-id><pub-id pub-id-type="pmid">35054002</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>H-J</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name></person-group>. <article-title>Global trends in the proportion of macrolide-resistant <italic>M. pneumoniae</italic> infections: a systematic review and meta-analysis</article-title>. <source>JAMA Netw Open</source>. (<year>2022</year>) <volume>5</volume>(<issue>7</issue>):<fpage>e2220949</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.20949</pub-id><pub-id pub-id-type="pmid">35816304</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name></person-group>. <article-title>The risk factors of children acquiring refractory <italic>M. pneumoniae</italic> pneumonia: a meta-analysis</article-title>. <source>Medicine</source>. (<year>2021</year>) <volume>100</volume>(<issue>11</issue>):<fpage>e24894</fpage>. <pub-id pub-id-type="doi">10.1097//MD.00000000000248894</pub-id><pub-id pub-id-type="pmid">33725960</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>HM</given-names></name><name><surname>Qian</surname><given-names>SY</given-names></name></person-group>. <article-title>Treatment of refractory, fulminant, and macrolide-resistant <italic>M. pneumoniae</italic> pneumonia</article-title>. <source>Chin J Pediatr Emerg Med</source>. (<year>2021</year>) <volume>28</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.1673-4912.2021.01.001</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>HJ</given-names></name></person-group>. <article-title>Analysis of risk factors and predictive value of refractory Mycoplasma pneumoniae pneumonia in children [J]</article-title>. <source>Chin J Mod Drug Appl</source>. (<year>2024</year>) <volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.14164/j.cnki.cn11-5581/r.2024.01.001</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>SY</given-names></name><name><surname>Jwa</surname><given-names>HJ</given-names></name><name><surname>Yang</surname><given-names>EA</given-names></name><name><surname>Kil</surname><given-names>HR</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name></person-group>. <article-title>Effects of methylprednisolone pulse therapy on refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Allergy Asthma Immunol Res</source>. (<year>2014</year>) <volume>6</volume>(<issue>1</issue>):<fpage>22</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4168/aair.2014.6.1.22</pub-id><pub-id pub-id-type="pmid">24404389</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>YG</given-names></name><name><surname>Wu</surname><given-names>JZ</given-names></name></person-group>. <article-title>Clinical features and treatment of refractory <italic>M. pneumoniae</italic> pneumonia unresponded to conventional dose methylprednisolone in children</article-title>. <source>Zhonghua Er Ke Za Zhi</source>. (<year>2014</year>) <volume>52</volume>(<issue>3</issue>):<fpage>172</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.0578-1310.2014.03.003</pub-id><pub-id pub-id-type="pmid">24824385</pub-id></citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>YD</given-names></name><name><surname>Wei</surname><given-names>YZ</given-names></name><name><surname>Jiang</surname><given-names>WJ</given-names></name><name><surname>Hao</surname><given-names>C</given-names></name></person-group>. <article-title>The clinical characteristics of corticosteroid-resistant refractory <italic>M. pneumoniae</italic> pneumonia in children</article-title>. <source>Sci Rep</source>. (<year>2016</year>) <volume>6</volume>:<fpage>39929</fpage>. <pub-id pub-id-type="doi">10.1038/srep39929</pub-id><pub-id pub-id-type="pmid">28008989</pub-id></citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>MI</given-names></name><name><surname>Zada</surname><given-names>N</given-names></name><name><surname>Aziz</surname><given-names>F</given-names></name><name><surname>Saeed</surname><given-names>Y</given-names></name><name><surname>Zeb</surname><given-names>A</given-names></name><name><surname>Ali Shah</surname><given-names>SA</given-names></name><etal/></person-group> <article-title>Prediction of future terrorist activities using deep neural networks</article-title>. <source>Complexity</source>. (<year>2020</year>) <volume>2020</volume>:<fpage>1373087</fpage>. <pub-id pub-id-type="doi">10.1155/2020/1373087</pub-id></citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Indrawan</surname><given-names>G</given-names></name><name><surname>Sudiarsa</surname><given-names>IKP</given-names></name><name><surname>Agustini</surname><given-names>K</given-names></name><name><surname>Sariyasa</surname><given-names>S</given-names></name></person-group>. <article-title>Smooth support vector machine for suicide-related behaviours prediction</article-title>. <source>Int J Electr Comput Eng</source>. (<year>2018</year>) <volume>8</volume>(<issue>5</issue>):<fpage>3399</fpage>. <pub-id pub-id-type="doi">10.11591/ijece.v8i5.pp3399-3406</pub-id></citation></ref></ref-list>
</back>
</article>